home News and Events Korea Pharma and Bio News
Total 146, Pages 6 /0
No. | Title | Link to a new window | Writer |
---|---|---|---|
96 | Novel lung cancer drug’s success hinges on safety verification | 관리자 | |
95 | Helixmith proves combined efficacy of its ADHD treatment | 관리자 | |
94 | Korea’s ezetimibe-statin combo drug market grew 20% last year | 관리자 | |
93 | Local biosimilar makers speed up commercializing pipelines | 관리자 | |
92 | Daewoong to conduct P3 trials of 1st Covid-19 preventive oral medicine | 관리자 | |
91 | Hepatitis B drug Vemlidy continues sales growth for 3rd year | 관리자 | |
90 | Gout drug colchicine emerges as Covid-19 treatment | 관리자 | |
89 | Lunit, GI Innovation to co-develop innovative new drugs | 관리자 | |
88 | Hanall Biopharma’s sales, profit plunged due to Covid-19 | 관리자 | |
87 | Daewoong jumps into cell therapy market as CDMO player | 관리자 |